Clinical Trials on Multiple Endocrine Neoplasia in New Zealand
Total 19370 results
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisNew Zealand, Australia
-
Innate ImmunotherapeuticsNational Multiple Sclerosis Society; Primorus Clinical TrialsCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisNew Zealand
-
University of Auckland, New ZealandNorth Shore Hospital, New Zealand; Waikato Hospital; Gut Cancer Foundation, New...Not yet recruitingIntraductal Papillary Mucinous Neoplasm of PancreasNew Zealand
-
Jersey Shore University Medical CenterRutgers University; Rutgers Cancer Institute of New JerseyCompletedPancreatic Cancer | Parathyroid Disease | Thymic Cancer | MEN1 SyndromeUnited States
-
Innate ImmunotherapeuticsSyneos HealthCompletedSecondary Progressive Multiple SclerosisNew Zealand, Australia
-
University of Auckland, New ZealandAuckland Medical Research Foundation; Mercia Barnes Trust of the Royal Australian...CompletedPolycystic Ovary SyndromeNew Zealand
-
University of Auckland, New ZealandWaitemata District Health Board; Counties Manukau Health; Auckland District Health...Completed
-
OncoMed Pharmaceuticals, Inc.Novotech (Australia) Pty LimitedCompletedPancreatic CancerAustralia, New Zealand, Spain
-
University of Auckland, New ZealandCompleted
-
Insulet CorporationCompleted
-
North Shore Hospital, New ZealandCompletedObesity | Type 2 Diabetes MellitusNew Zealand
-
Australian and New Zealand Intensive Care Research...Baxter Healthcare CorporationCompletedCritical Illness | Multiple Organ FailureAustralia, New Zealand
-
Diatranz Otsuka LimitedCompleted
-
University of OtagoEdgar National Centre for Diabetes ResearchCompletedObesity | Type 2 Diabetes MellitusNew Zealand
-
Zhejiang Doer Biologics Co., Ltd.RecruitingHealthy, Obesity, MetabolicallyNew Zealand
-
Edgar National Centre for Diabetes ResearchUniversity of OtagoUnknown
-
Christchurch Clinical Studies Trust LtdMedtronicUnknownType1diabetesNew Zealand
-
Christchurch HospitalUnknownDiabetes Mellitus, Type 2New Zealand
-
ABK BiomedicalCompletedMetastatic Colorectal Cancer | Liver Cancer | Hepatocellular Carcinoma Non-resectableNew Zealand
-
University of Auckland, New ZealandWaitemata District Health Board; Counties Manukau HealthCompletedColorectal Cancer | Surgery | Perioperative Care | ColectomyNew Zealand
-
MetaventionCompletedDiabetes | Endocrine, Nutritional and Metabolic Diseases (E00-E89)New Zealand
-
Middlemore Hospital, New ZealandUnknown
-
Auckland District Health BoardNovartis; University of Auckland, New Zealand; IGENZ, Ltd., AucklandUnknownClear Cell Renal Cell CarcinomaNew Zealand
-
Provectus PharmaceuticalsCompleted
-
OcuNexus Therapeutics, Inc.TerminatedDiabetic Foot UlcerNew Zealand
-
Karyopharm Therapeutics IncWithdrawnDiabetic Foot UlcersNew Zealand
-
Trans Tasman Radiation Oncology GroupFisher and Paykel Healthcare; Auckland City HospitalCompletedCancer of the Head and NeckNew Zealand
-
Waikato HospitalWellington HospitalRecruitingGlioblastomaNew Zealand
-
Malaghan Institute of Medical ResearchRecruitingLymphoma | Leukemia | Myeloma | Temperature Change, Body | Haematological MalignancyNew Zealand
-
Hoosier Cancer Research NetworkUniversity of Sydney; Bionomics Limited; Australia New Zealand Gynaecological...WithdrawnOvarian CancerUnited States, Australia, New Zealand
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple MyelomaUnited States, New Zealand
-
Hoffmann-La RocheCompleted
-
Proacta, IncorporatedCompletedUnspecified Adult Solid Tumor, Protocol SpecificNew Zealand
-
Neothetics, IncCompletedThyroid-Related Eye DiseaseAustralia, New Zealand
-
Novartis PharmaceuticalsTerminated
-
University of Auckland, New ZealandCounties Manukau Health; Waikato Hospital; Cancer Trials New ZealandActive, not recruiting
-
Malaghan Institute of Medical ResearchWellington Zhaotai Therapies Limited (WZTL)RecruitingMantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Lymphomas Non-Hodgkin's B-Cell | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL)New Zealand
-
Living Cell TechnologiesCompletedParkinson's DiseaseNew Zealand
-
Living Cell TechnologiesStatistecol Consultants LimitedCompleted
-
State University of New York at BuffaloCompletedSecondary-progressive Multiple SclerosisUnited States
-
NeuroActiva, Inc.CompletedNeurocognitive Disorders | Neurodegenerative Diseases | Cognitive Impairment | Alzheimer Disease | Tauopathies | Mild Cognitive Impairment | Dementia, Vascular | Dementia With Lewy Bodies | Alzheimer Dementia | Cognitive DisorderNew Zealand
-
Novartis PharmaceuticalsCompletedMayzent (Siponimod) Onboarding of Secondary Progressive Multiple Sclerosis (SPMS) Patients With MSGoSecondary Progressive Multiple SclerosisAustralia
-
Targovax ASATerminated
-
Antisoma ResearchCompletedMetastatic Renal Cell Carcinoma | Metastatic Malignant MelanomaUnited Kingdom, New Zealand
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)TerminatedMucositis | Xerostomia | Radiation Toxicity | Stage III Squamous Cell Carcinoma of the Hypopharynx | Stage III Squamous Cell Carcinoma of the Larynx | Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage III Squamous Cell Carcinoma of the Nasopharynx | Stage III Squamous Cell Carcinoma... and other conditionsUnited States, New Zealand
-
BiogenBiogen Idec A/SCompletedExerciseSweden, Finland, New Zealand, Denmark, Norway, Australia
-
Immune ControlCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Geneos TherapeuticsActive, not recruitingHCCUnited States, New Zealand
-
NGM Biopharmaceuticals, IncNGM Biopharmaceuticals Australia Pty LtdCompleted
-
Agenus Inc.Terminated